Harvest ETFs Announces May 2025 Distributions
OAKVILLE, Ontario — Harvest Portfolios Group Inc. ('Harvest') announces the following distributions for Harvest ETFs for the month ending May 31, 2025. The distribution will be paid on or about June 9, 2025 to unitholders of record on May 30, 2025 with an ex-dividend date of May 30, 2025.
Article content
Article content
Harvest has established a Distribution Reinvestment Plan ('DRIP') for certain classes of Harvest ETFs, allowing investors to easily benefit from compounding their distributions on a monthly basis. Certain Harvest ETFs listed on the Toronto Stock Exchange (TSX) are eligible for the Distribution Reinvestment Plan, provided that their investment dealer supports participation in the DRIP. Investors may opt into the DRIP by contacting their investment dealer, otherwise distributions will be paid in cash.
Article content
Harvest ETF
TSX Ticker
Distribution
Harvest Healthcare Leaders Income ETF
HHL
$0.0600 per unit
Harvest Healthcare Leaders Income ETF (US)
HHL.U
$0.0600 per unit
Harvest Healthcare Leaders Income ETF (Unhedged)
HHL.B
$0.0600 per unit
Harvest Brand Leaders Plus Income ETF
HBF
$0.0650 per unit
Harvest Brand Leaders Plus Income ETF (US)
HBF.U
$0.0650 per unit
Harvest Brand Leaders Plus Income ETF (Unhedged)
HBF.B
$0.0650 per unit
Harvest Energy Leaders Plus Income ETF
HPF
$0.0250 per unit
Harvest Energy Leaders Plus Income ETF (US)
HPF.U
$0.0250 per unit
Harvest Tech Achievers Growth & Income ETF
HTA
$0.1400 per unit
Harvest Tech Achievers Growth & Income ETF (US)
HTA.U
$0.1400 per unit
Harvest Tech Achievers Growth & Income ETF (Unhedged)
HTA.B
$0.1400 per unit
Harvest Global REIT Leaders Income ETF
HGR
$0.0458 per unit
Harvest US Bank Leaders Income ETF
HUBL
$0.1000 per unit
Harvest US Bank Leaders Income ETF (US)
HUBL.U
$0.1000 per unit
Harvest Equal Weight Global Utilities Income ETF
HUTL
$0.1216 per unit
Harvest Diversified Monthly Income ETF
HDIF
$0.0741 per unit
Harvest Canadian Equity Income Leaders ETF
HLIF
$0.0583 per unit
Harvest Healthcare Leaders Enhanced Income ETF
HHLE
$0.0934 per unit
Harvest Tech Achievers Enhanced Income ETF
HTAE
$0.1600 per unit
Harvest Equal Weight Global Utilities Enhanced Income ETF
HUTE
$0.0880 per unit
Harvest Diversified Equity Income ETF
HRIF
$0.1100 per unit
Harvest Travel & Leisure Income ETF
TRVI
$0.1600 per unit
Harvest Premium Yield Treasury ETF
HPYT
$0.1500 per unit
Harvest Premium Yield Treasury ETF (US)
HPYT.U
$0.1500 per unit
Harvest Premium Yield Treasury ETF (Unhedged)
HPYT.B
$0.1500 per unit
Harvest Premium Yield 7-10 Year Treasury ETF
HPYM
$0.0800 per unit
Harvest Premium Yield 7-10 Year Treasury ETF (US)
HPYM.U
$0.0800 per unit
Harvest Balanced Income & Growth ETF
HBIG
$0.1600 per unit
Harvest Balanced Income & Growth Enhanced ETF
HBIE
$0.2000 per unit
Harvest Industrial Leaders Income ETF
HIND
$0.0700 per unit
Harvest Low Volatility Canadian Equity Income ETF
HVOI
$0.0800 per unit
Harvest Bitcoin Enhanced Income ETF
HBIX
$0.2400 per unit
Harvest Bitcoin Leaders Enhanced Income ETF
HBTE
$0.3300 per unit
Article content
Note: Harvest ETFs that trade in US dollars with TSX Ticker ending in '.U' pay the distribution in US dollars.
Article content
The estimated distribution will be paid on or about June 9, 2025 to unitholders of record on May 30, 2025 with an ex-dividend date of May 30, 2025 for the ETF below. The final distribution amount will be announced May 29, 2025.
Article content
For additional information: Please visit www.harvestportfolios.com, e-mail info@harvestetfs.com or call toll free 1-866-998-8298.
Article content
Founded in 2009, Harvest is an independent Canadian Investment Fund Manager managing $6.4 billion in assets for Canadian Investors. At Harvest ETFs, we believe that investors can build and preserve wealth through the long-term ownership of high-quality businesses. This fundamental philosophy is at the core of our investment approach across our range of ETFs. Our core offerings center around covered call strategies, available in five variations: Equity, Enhanced, Fixed Income, Balanced and Single Stock ETFs.
Article content
You will usually pay brokerage fees to your dealer if you purchase or sell shares of the investment fund on the TSX. If the shares are purchased or sold on the TSX, investors may pay more than the current net asset value when buying shares of the investment fund and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning shares of an investment fund. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into Class A, Class B or Class U units of the Fund. If the Fund earns less than the amounts distributed, the difference is a return of capital. An investment fund must prepare disclosure documents that contain key information about the investment fund. You can find more detailed information about the investment fund in these documents.
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a minute ago
- Globe and Mail
Adtran (ADTN) Q2 Revenue Jumps 17%
Key Points Revenue (GAAP) exceeded expectations at $265.1 million in Q2 2025, up 17% year over year (GAAP). Non-GAAP operating margin rose to 3.0%, from 0.6% in Q2 2024. These 10 stocks could mint the next wave of millionaires › Adtran (NASDAQ:ADTN), a provider of fiber networking equipment and solutions for communications networks, released its second quarter 2025 results on August 5, 2025. The company delivered revenue (GAAP) of $265.1 million in Q2 2025—well above both management's guidance and analyst GAAP estimates of $260.2 million. Non-GAAP operating margin improved to 3.0%, and Free cash flow (non-GAAP) increased from $3.9 million in Q2 2024 to $18.3 million. However, adjusted earnings per share (non-GAAP) were break-even, and profitability remains a work in progress, despite year-over-year improvement. The quarter showed clear top-line outperformance, as GAAP revenue of $265.1 million exceeded the analysts' estimate by approximately 1.9%, but sustainable profit levels and margin expansion are areas to watch. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change EPS (Non-GAAP) $(0.00) N/A $(0.13) 100.0 % Revenue (GAAP) $265.1 million $260.2 million $226.0 million 17.3 % Gross Margin (Non-GAAP) 41.4 % 41.8 % (0.4 pp) Operating Margin (Non-GAAP) 3.0 % 0.6 % 2.4 pp Free Cash Flow (Non-GAAP) $18.3 million $3.9 million 369.2 % Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q2 2025 earnings report. What Adtran Does and Where It's Focused Adtran builds and supplies hardware and software to companies and telecom carriers that need high-speed, fiber-optic-based network infrastructure. Its main products range from access platforms that connect homes and businesses to fiber grids, to tools that help manage and secure growing network traffic. Its recent focus revolves around becoming a leader in fiber networking, expanding into international markets, and tightening operational efficiency. Critical to success are Adtran's innovation pipeline—in other words, how quickly and effectively it develops new products—and its ability to win share from competitors. The company also emphasizes investment in research and development, which supports future product launches and maintains technical differentiation in a crowded field. Quarter in Review: Revenue Beat, Mixed Margins, and Cash Progress Results exceeded both internal guidance and outside expectations, with total revenue (GAAP) up 17% year-over-year compared to Q2 2024. The Network Solutions business—which focuses on fiber networking products—saw notable growth, rising 22.5% from $179.2 million in Q2 2024 to $219.5 million (GAAP). However, the Services & Support segment (GAAP) declined 2.6% to $45.6 million compared to Q2 2024, capturing share in what management describes as 'key areas,' even though details by region or customer group were not provided. Margins (GAAP and non-GAAP) moved in a positive direction on a year-over-year basis, though the picture is not uniformly strong. Non-GAAP operating margin improved to 3.0%, compared with 0.6% in the prior-year quarter, while non-GAAP gross margin held above 41%. Compared with the prior quarter, though, both GAAP and non-GAAP gross and operating margins fell slightly, suggesting some pressure on profitability despite better sales. With cost savings from its Business Efficiency Program now largely realized. Operationally, the company made progress in generating cash. Operating cash flow (GAAP) was $32.2 million, up from $19.9 million in Q2 2024. Free cash flow (non-GAAP) jumped to $18.3 million from $3.9 million in Q2 2024. Cash and equivalents (GAAP) were $106.3 million as of June 30, 2025, reflecting stronger cash generation on growing sales. Research and development spending (GAAP) came to $51.9 million, down from $60.4 million in Q2 2024. However, Selling, general, and administrative costs (GAAP) were stable year over year. Fiber Networking Leadership and Competition Adtran's main product families include fiber access platforms—hardware systems that deliver high-speed fiber connections to homes and businesses. As stated by CEO Tom Stanton: 'We delivered strong Q2 2025 results with GAAP revenue growth that exceeded expectations.' The focus on network core-to-edge solutions positions the company competitively as bandwidth needs rise with trends like cloud adoption and artificial intelligence. Competitive pressure remains intense, with larger network equipment providers such as Nokia, Huawei, and Ciena also vying for market dominance. Maintaining non-GAAP gross margins above 40% suggests the company continues to compete on technology rather than price alone. Management reported that business efficiency initiatives are now largely complete. The company reported ongoing material weaknesses in its internal controls for financial reporting. Adtran does not currently pay a dividend. Looking Ahead: Guidance and Key Areas for Investors Management provided a financial outlook, guiding revenue to a range of $270.0 million to $280.0 million. At the midpoint, this projects sequential growth of 3.7%. Non-GAAP operating margin is expected in the 3.0% to 7.0% range, signaling intent to build on the improvement seen this period. However, no additional specifics on bookings or detailed segment expectations were shared. Investors should monitor whether margin progress continues, as both gross and operating margins (GAAP and non-GAAP) softened slightly from the previous quarter. Areas to watch in the months ahead include the sustainability of Network Solutions growth, R&D spending levels, and whether the company can make further headway toward profitability. Management remains focused on increasing efficiency and broadening its fiber portfolio to support long-term strategic goals. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. *Stock Advisor returns as of August 4, 2025 JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Globe and Mail
25 minutes ago
- Globe and Mail
LifeMD (LFMD) Q2 Revenue Rises 23%
Key Points Revenue grew 23% year over year (GAAP) in Q2 2025, but missed analyst estimates by $4.1 million (GAAP). The telehealth segment achieved 30.0% revenue growth, with Adjusted EBITDA rising 560%. Management cut full-year 2025 guidance across all major metrics due to Rex MD challenges, lowering total revenue guidance to $250 million–$255 million, telehealth revenue to $195 million–$200 million, adjusted EBITDA to $27 million–$29 million, and telehealth adjusted EBITDA to $14 million–$16 million. These 10 stocks could mint the next wave of millionaires › LifeMD (NASDAQ:LFMD), a telehealth platform specializing in virtual care and digital health subscriptions, reported its second quarter 2025 financial results on August 5, 2025. Revenue (GAAP) was $62.2 million, up 23% from the same period last year but $4.1 million below consensus estimates (GAAP). Earnings per share (EPS) came in at a loss of $0.06 (GAAP), which was also below analyst expectations by $0.0517 (GAAP). Despite year-over-year expansion in core business metrics, results missed both revenue and GAAP earnings projections. The quarter showcased strong telehealth growth and improved operational profitability, but also included a guidance reduction for the full year, pointing to segment-specific pressures, especially within men's health. Overall, the period highlighted robust subscriber and adjusted EBITDA gains alongside mounting challenges in forecasting and segment execution. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change EPS (GAAP) ($0.06) ($0.01) ($0.19) Improved Revenue (GAAP) $62.2 million N/A $50.7 million 22.8 % Adjusted EBITDA $7.1 million $2.2 million 223% Telehealth Revenue $48.6 million $37.4 million 30.0 % Telehealth Adjusted EBITDA $3.4 million $0.5 million 580 % Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Understanding LifeMD's Business Model and Key Growth Factors LifeMD delivers virtual healthcare services directly to consumers in all 50 states, focusing on subscription-based telehealth for chronic condition management, primary care, and specialty health segments. It operates two main businesses: a telehealth segment delivering care through a vertically integrated platform (including pharmacy and labs), and WorkSimpli, a smaller software platform targeting administrative business solutions. In recent quarters, LifeMD has sharpened its emphasis on recurring telehealth subscriptions, platform expansion, and expansion into new clinical verticals such as behavioral and women's health. Key drivers for success include strong regulatory compliance, platform-driven patient retention, and the ability to introduce services efficiently at scale. Partnerships with healthcare brands and continued technology investment also feature heavily among its strategies for differentiation and sustainable growth. Quarterly Highlights and Segment Performance LifeMD's total revenue (GAAP) climbed 23% year over year, led by a 30% surge in telehealth segment revenue and a significant jump in operational profitability, as reflected by adjusted EBITDA (non-GAAP) increasing to $7.1 million from $2.2 million in Q2 2024. Active telehealth subscribers reached nearly 297,000, up 16% year over year. However, while overall revenue grew, the outcome was $4.1 million behind analyst forecasts on a GAAP basis, highlighting gaps versus external expectations. The telehealth segment continues to be LifeMD's main growth engine. Telehealth Adjusted EBITDA, a non-GAAP measure used to assess core profitability before certain accounting deductions, surged 560% to $3.4 million from the year-ago period. The segment benefited from strong demand for subscription-based chronic care, weight management, and expanded men's health services such as hormone therapy. Management reported that new offerings in behavioral and women's health delivered limited revenue during the quarter, but these areas are expected to contribute more materially over time. WorkSimpli revenue (GAAP) edged up 3% compared to the same period last year, active subscribers in this segment fell 6%, as the company shifted its strategy to focus on higher-value, longer-term clients rather than maximizing subscriber count. As a result, WorkSimpli's adjusted EBITDA more than doubled compared to Q2 2024, underscoring the company's drive to maximize cash flow from this asset ahead of any potential future divestiture. Gross margin, which measures the proportion of revenue retained after accounting for direct service costs, slipped to 88% from 90% last year (GAAP). Management attributed this margin compression chiefly to changes in revenue mix, as the telehealth segment's component services grew at varying rates. Operating cash flow was robust, exceeding $8 million, and the company ended the period with a cash position of $36.2 million after fully repaying its senior debt post-quarter. LFMD does not currently pay a dividend. Key Business Developments, Risks, and Strategic Initiatives Several forces shaped LifeMD's second quarter. First, the company's rapid expansion in telehealth continued as it grew recurring, subscription-based revenue streams and lifted its active user base. Telehealth subscriptions remain the backbone of LifeMD's financial model, accounting for most segment revenue. The company took notable steps to widen its clinical reach. It launched a national behavioral health service, providing both real-time (synchronous) and on-demand (asynchronous) care for mental health. Through a recent acquisition, it is rolling out subscription-based virtual women's health programs, starting with VIP concierge offerings and plans to extend to broader insurance-supported and cash-pay options. In parallel, LifeMD enhanced its LifeMD+ membership program to aggregate telehealth, pharmacy, laboratory, and wellness services under one umbrella for better patient retention. From a financial perspective, cost discipline played a visible role, as selling and marketing expenses increased, but general and administrative spending was trimmed year on year. The company succeeded in improving net losses (GAAP) from $7.7 million to $2.9 million versus Q2 2024. and more than tripled its overall Adjusted EBITDA (non-GAAP). At the same time, margin pressure appeared, as gross margins (GAAP) dipped to 88% from 90% in Q2 2024, reflecting a greater share of lower-margin revenue. Legal and regulatory risk remains the most notable external issue, particularly surrounding LifeMD's reliance on the supply of GLP-1 weight-loss medications. Shifts in either FDA policy or supply dynamics could have a direct effect on future results. Strategic partnerships made headlines this quarter. LifeMD moved forward with collaborations with weight management drug providers LillyDirect and NovoCare, aimed at helping patients access branded therapies like Wegovy and Zepbound when lacking insurance. The company does not receive financial incentives from these collaborations, which it views as a competitive advantage in virtual obesity care. Early revenue from these verticals remains small, and integration is ongoing. On the technology front, the company remains aggressive, capitalizing on its proprietary telehealth infrastructure, pharmacy network, software, and integrated patient experience. Platform upgrades, enhanced CRM (customer relationship management) systems, and new patient-facing technology continued as investment priorities, fueling opportunities to bring new services to market more quickly and deepen relationship-based retention. Despite top-line growth, mounting uncertainty underpinned the revised full-year outlook. In response to challenges in the Rex MD men's health brand -- involving both business execution and regulatory complexity -- LifeMD lowered its forward guidance for total revenue, telehealth revenue, and Adjusted EBITDA for the full year. Guidance now stands at $250–$255 million in total revenue (GAAP basis), $195–$200 million telehealth revenue (GAAP, full year), and $27–$29 million in Adjusted EBITDA for the full year, as both market conditions and regulatory situations continue evolving. Looking Forward: Guidance and Investor Considerations For Q3 2025, LifeMD's leadership projects total revenue between $61 million and $63 million, with telehealth revenue expected to contribute $48 million to $50 million and Adjusted EBITDA ranging from $6 million to $7 million. Management does not expect a material one-time boost from newly launched verticals or drug collaborations for the remainder of the year, though moderate growth is reflected from early ramp-up in women's and behavioral health. These updates represent a notable reduction from previous management forecasts, reflecting ongoing impacts from earlier Rex MD disruptions. The company's near-term performance will depend on its ability to stabilize subscriber growth, control marketing and service costs, and successfully integrate new verticals without additional unforeseen challenges. Ongoing legal actions and changing rules around compounded drugs remain watch points for the business and shareholders alike. LFMD does not currently pay a dividend. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025
CBC
32 minutes ago
- CBC
Fraser valley organics company relocates piles of illegal waste to another unauthorized site
News Duration 2:35 Fraser valley organics company relocates piles of illegal waste to another unauthorized site
